Changes in Plasma Fibrinogen, Viscosity and Electrolyte Levels among Some Nigerian Diabetics Receiving Treatment

Author(s):
I OnyesomI Onyesom*,+
+Corresponding Author: P.O. Box 144, Abraka, Delta State, Nigeria, [email protected]. Tel: +234 803 052 8016. Email: [email protected]

Shiraz E-Medical Journal:Vol. 7, issue 3; 1-6
Published online:Aug 31, 2006
Article type:Research Article
Received:Aug 01, 2006
Accepted:Sep 11, 2006
How to Cite:Onyesom I. Changes in Plasma Fibrinogen, Viscosity and Electrolyte Levels among Some Nigerian Diabetics Receiving Treatment. Shiraz E-Med J. 2006;7(3):e20402. doi:

Abstract

In order to assess the impact of the various treatment approaches adopted to manage diabetes mellitus (DM) in Nigeria, one hundred and ninety-five fresh cases of DM were investigated. Fifty-five non-diabetic individuals in apparent good health were included as control subjects. The DM patients were separated into 3 groups depending on the treatment they received. Group 1: diet, 2: insulin, and 3: oral hypoglycemic drugs. Basal plasma fibrinogen concentration (PFC), relative plasma viscosity (RPV), packed cell volume (PCV), hemoglobin (Hb) concentration, plasma sodium and potassium levels were determined in both DM patients and control subjects by standard analytical procedures, and the results were compared with those obtained after about 61 (5-7) months of managing the ailment. The data indicate that after about 5-7 months treatment of the disease, PFC for group 1 patients (4.003.0g/L; n=75) and plasma sodium levels (130.04.6mmol/L: n=75;134.23.2mmol/L: n=55; and 132.14.3mmol/L: n=65) for groups 1,2 and 3 DM patients were demonstrated to be significantly different (P<0.05) when compared with control values (PFC=3.020.31g/L; sodium=142.33.2mmol/L: n=53) using the Student t-test. Results suggest poor control of DM by diet and drug, and this may be due to patients non-compliance to recommended diets and drug dosage. Since not all cases require insulin administration in the first instance, then ways of enforcing strict compliance should be explored and tested.

Full Text

Full text is available in PDF

Copyright

© 2006, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

31
Mar
2001

Diabetes control and its relationship with HbA1c and blood sugar

AA Hajagha Mohammadi,
N. Esmaeili

Hajagha Mohammadi A, Esmaeili N. Diabetes control and its relationship with HbA1c and blood sugar. J Inflamm Dis. 2024;4(4):e154790. doi:

31
Dec
2006

Comparision of fructosamine test with glycated hemoglobin in assessing diabetes

S Mahdavifard,
B Jalali

Mahdavifard S, Jalali B. Comparision of fructosamine test with glycated hemoglobin in assessing diabetes. J Inflamm Dis. 2024;10(3):e155238. doi:

30
Jun
2007

Evaluation of correlation between fructosamine and glycated hemogolobin

s MMahdavifard,
BA Jalali

MMahdavifard S, Jalali B. Evaluation of correlation between fructosamine and glycated hemogolobin. J Inflamm Dis. 2024;11(1):e155278. doi:

1
Sep
2021

Associated factors of poor glycemic control in Iranian diabetic patients

Soraya Doustmohamadian,
Naeim sadat Kia,
Sepideh Fatahi

Doustmohamadian S, Kia NS, Fatahi S. Associated factors of poor glycemic control in Iranian diabetic patients. koomesh. 2021;23(3):e149956. doi:

Download PDF83.91 KB
Share on
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC